Highbridge Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21M Buy
861,837
+823,198
+2,130% +$8.79M 0.22% 99
2026
Q1
$408K Buy
+38,639
New +$407K 0.01% 165

Other funds holding TDAC

Highbridge Capital Management's TDAC Position: Q2 2026 in Review

Highbridge Capital Management increased its Translational Development Acquisition Corp (TDAC) stake by 2,130% in Q2 2026, buying an estimated $8.79M and bringing the position to 861,837 shares worth $9.21M. The position accounts for 0.22% of the portfolio, ranked #99.

Highbridge Capital Management first reported a position in TDAC in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Highbridge Capital Management held 861,837 shares of Translational Development Acquisition Corp worth $9.21M as of Q2 2026.
  • Highbridge Capital Management bought 823,198 Translational Development Acquisition Corp shares in Q2 2026, an estimated $8.79M.
  • Translational Development Acquisition Corp made up 0.22% of Highbridge Capital Management's portfolio in Q2 2026, its #99 holding.
  • Highbridge Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2026 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.